SGLT2 inhibitors in heart failure: New analyses and recent updates

John J V McMurray.
University of Glasgow. Cardiovascular Research Center.
Institute of Cardiovascular and Medical Sciences. UK.

[@b.a.d.2086]

80 year old, non diabetic HFpEF patient here. SGLT2i has made a wonderful difference, no side effects except good ones! Please don't leave out the oldest patients! This drug is a very big game changer that all ages need to be able to use.

[@charalamposstefanidis463]

Congratulations.Many thanks for your excellent presentation!

[@RishSwr2024]

nice presentation!!!